Schrøder Preben
Theriaca. 2005(36):27-118.
A chronological exposition of the history of LEO Pharma from the limited beginnings in 1908 in "København Løveapotek" to the international pharmaceutical company that exists today. The paper chronicles the various owners, from the pharmacist, August Kongsted, through his son-in-law, Knud Abildgaard to the present ownership by the LEO Foundation, which has during the entire period secured a company independent of foreign capital. Research, the life blood of the company, has resulted in a number of outstanding drugs such as hormones, heparin, diuretics, penicillin, Fucidin, alfacalcidol and calcipotriol. The company's headquarters are based in Ballerup close to Copenhagen. Further to a large research centre and production facilities in Denmark, LEO Pharma has affiliates in almost 100 countries and a number of European manufacturing sites. With 3500 employees across the globe and a yearly turnover of DKK 4.5 billion, LEO is now firmly established. Throughout the years LEO Pharma has been active within a number of other fields like agricultural feedstuff, veterinary medicine and medical utensils, but today LEO Pharma works only in human medicine. Over the years LEO Pharma has contributed to the foundation of companies like Nordisk Insulin, Ferrosan and LEO AB in Sweden.
利奥制药公司的历史编年阐述,从1908年在“哥本哈根洛夫药店”的有限起步,到如今的国际制药公司。本文记录了历任所有者,从药剂师奥古斯特·孔斯泰德,到他的女婿克努德·阿比尔加德,再到如今由利奥基金会持有,该基金会在整个时期确保了公司独立于外国资本。作为公司的命脉,研发催生了许多杰出药物,如激素、肝素、利尿剂、青霉素、夫西地酸、阿法骨化醇和卡泊三醇。公司总部位于哥本哈根附近的巴勒鲁普。除了在丹麦拥有大型研发中心和生产设施外,利奥制药在近100个国家设有分支机构,并在欧洲有多个生产基地。利奥制药在全球拥有3500名员工,年营业额达45亿丹麦克朗,如今已稳固立足。多年来,利奥制药还活跃于其他一些领域,如农业饲料、兽药和医疗器械,但如今利奥制药仅专注于人类医学领域。多年来,利奥制药为诺和诺德胰岛素公司、费罗桑公司和瑞典的利奥AB公司等企业的创立做出了贡献。